Pharmacy News

DEA commits to expand access to MAT

DEA administrator Anne Milgram announced the agency’s continued support for expanding access to medication-assisted treatment (MAT) to help individuals with substance use disorder.

New bill would ensure patient access to essential services by pharmacists

On March 24, Congressman Ron Kind (D-WI), Congressman David B. McKinley (R-WV), Congresswoman Nanette Diaz Barragán (D-CA), and Congressman Buddy Carter (R-GA) introduced the Equitable Community Access to Pharmacist Services Act, a groundbreaking piece of legislation that would allow Medicare patients to continue to receive treatment from pharmacists for pandemic-related health services and would permit pharmacists to respond to ongoing and future public health crises.

Pharmacy meets digital health at DigitalHealth.Rx summit

We’ll see soon that digital health is simply health care, said Daniel Zlott, PharmD, APhA’s senior vice president of education and business development, during APhA’s second annual DigitalHealth.Rx summit, which was held in-person on March 17, in conjunction with APhA2022 in San Antonio, TX.

Sandra Leal Amplifying Our Voices

Sandra Leal, APhA President, 2021–2022 shared words of gratitude as well as the importance and value of advocacy in her #APhA2022 Presidential Speech, “Amplifying Our Voice.”

Could famotidine reduce COVID-19 symptoms?

According to outpatient clinical trial results recently published in Gut, the common heartburn medication Pepcid (famotidine) could improve the recovery of symptomatic patients diagnosed with COVID-19.